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Abstract: The use of β-emitters for therapy purposes is one of the most extended procedures for tumor treatments in 
nuclear medicine practices over the last years. The constantly increasing dose delivery to healthy tissues in this 
practices, due to their high linear energy transfer and their radiobiological characteristics, might lead to complications in 
radiosensitive organs/tissues. Research efforts should be conducted to the development of tools and methods devoted 
to perform precise dosimetric calculations to deal with this issue and assess accurately dosimetric estimations on 
patients treated regions. 
When performing dosimetry at organ level it is usual to assume some approximations on calculations, like uniformity in 
activity distribution within source regions, homogeneous media distribution for patient treated regions and uniform 
delivered dose on target organs. In this work, a formula to obtain Dose Point Kernel for different biological media is 
presented. Results are collated with Monte Carlo simulations suggesting a behavior that can be splitted in three groups, 
in accordance to their differences against the stochastic estimations: a) skin, blood and brain present differences within 
the 5% in comparison with the reference data; b) skeletal muscle, soft tissue, striated muscle and adipose tissue have 
differences lower than 20%; and c) compact bone, cortical bone and lung tissue differences are found above 50%.  
This introduction of a medium-specific Dose Point Kernel calculation method could potentially lead to future 
improvements on dosimetric systems, limiting for now this model to tissues with effective atomic number closed to liquid 
water. 
Keywords: Dose point kernel, Radioisotope, Monte carlo simulation, Theoretical models, Targeted radionuclide 
therapy. 
1. INTRODUCTION 
There are several investigations devoted to 
Targeted Radionuclide Therapy (TRT) improvements in 
nuclear medicine procedures [1-3]. TRT uses specific 
amounts of radiopharmaceuticals aiming at leaving 
precise radioactivity concentrations inside and around 
tumor tissues in order to eliminate diseased cells. The 
metabolic relation between patient and carrier presents 
non uniform activity distributions within body tissues 
and organs, while in TRT dosimetric methods almost all 
current protocols and procedures assume uniform 
distribution inside source organs/regions. An accurate 
assessment of dose deposition on target and healthy 
tissues in TRT procedures is still a non-completely 
solved issue in routinely clinics. 
TRT dose distribution assessment can be carried 
out either by numerical or analytical methods. 
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Numerically, it can be inferred through Monte Carlo 
(MC) simulations [4, 5], and analytically it can be 
derived from S values tables [6, 7] or by the Dose Point 
Kernels (DPK) convolution [8, 9] taking into account 
data from media and radionuclides involved. When 
performing dosimetry at organ level, it is customary to 
introduce some approximations like assuming 
uniformity in the activity distribution within the source 
regions and/or homogeneous tissue distribution on 
treated patient region. Similarly, the absorbed dose in 
target organs is represented as being uniform within 
the corresponding volume. At organ level dosimetry, 
source region uniformly activity distribution assumption 
results in a uniform deposited dose within both target 
and healthy tissues. Whereas that at voxel level 
dosimetry S values tables have been recently 
calculated for several radionuclides commonly used in 
nuclear medicine procedures and DPK convolution 
provides a powerful tool when the involved media can 
be assumed homogeneous. 
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Nowadays, almost all used calculation tools in TRT 
are performed by a simplification of the Boltzmann 
radiation transport equation (RTE), taking into account 
infinite homogeneous media and then using the 
linearity principle to account for different dose 
contributions. On the other hand, MC simulations 
provide an accuracy in particle transport and energy 
delivery computation that cannot be achieved by 
analytical calculations. At present, new facilities allow 
high data processing that renders MC simulations an 
important tool to consider in the near future. The use of 
this tool to perform numerical calculations on complex 
systems allows to estimate accurate semi-analytical 
results [10]. 
The main goal of this work is to propose a model 
dedicated to analytical DPK assessment for dosimetric 
applications comprising different radionuclides of 
interest in nuclear medicine aiming at avoiding the high 
computational costs of performing them through MC 
simulations, or the intrinsic uncertainties of S values 
calculated on standard virtual phantoms. Thus, this 
model needs to be capable of estimating DPK curves 
for media of interest in nuclear medicine procedures, 
like different human tissues, by means of pre-
calculated and known DPK curves from a pattern 
medium, i.e. water. 
Some approaches have been carried out for soft 
tissues in terms of the RTE and it was found a simple 
formula to approximate several DPK radial distributions 
of interest from a known reference material. Liquid 
water was chosen as pattern because of its extended 
use for different purposes and the ease in finding it in 
published data. MC simulations have been run to 
obtain DPKs for comparing them with the estimations 
of the proposed approaching model. Finally, it was 
performed a comparison among simple applications on 
an arbitrary virtual phantom for the three analyzed 
calculation methods: MC simulation, traditional DPK 
convolution, and the DPK proposed model convolution. 
The most important aspect of making it possible, 
considering different media in electrons emissions, is 
their short range in such media at energies of interest 
for radiopharmaceutical applications. In TRT proce- 
dures, the possibility of considering the specific source 
organ tissue for dosimetric calculations results in a 
powerful tool to improve the accuracy of computing 
dose distributions at a sub-organ and voxel level. 
2. METHODS 
2.1. Background Theory 
2.1.1. Dose Approach by Means of Stopping Power 
Function 
The RTE in the Continuous Slowing Down 
Approximation (CSDA) is also known as the Lewis 
equation (1950) since it was presented as a formula to 
describe the electrons transport [11] and can be written 
as 
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where !t  and !e  are the total and elastic scattering 
macroscopic cross sections of the medium, 
respectively. Y (E) is the source density spectrum 
representing the number of electrons generated with 
energy between E and E + dE and S(E) is the stopping 
power function. Thus, when integrating over all the 
solid angle it becomes 
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where  !
!"(E,r)  refers to the vectorial expression of 
fluence and !(E,r) is the scalar fluence. The above 
integration cancels out all scattering terms. Therefore, 
by multiplying equation (2) by kinetic energy E and 
integrating them again, it is obtained that 
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where  !
!"! (r)  is the corresponding vectorial energetic 
fluence. Finally, when integrating by parts the first right 
term, it results in 
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Furthermore, the dose can also be expressed by [12] 
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from equation (5) it is observed that !Q = YE "Qr ; 
where YE is the total kinetic energy of emitted radiation 
by medium mass unit from the source and Qr is the net 
increment in rest energy by unit mass of the medium 
due to radiation. So, absorbed dose D turns out as 
D = ! (E, r) S (E)
"# dE            (6) 
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Now, the equation (6) expresses D by means of 
stopping power function, S(E) . 
2.1.2. Scaled DPK 
When considering DPK as a consequence of β 
particles radiation, it is customary to designate it as 
βDPK. Although this work considers only electron (β-
minus) sources, the term DPK will be used. It can be 
considered a simplified model of a point source 
isotropically emitting monoenergetic electrons moving 
through a homogeneous medium and loosing energy 
slowly and continuously (CSDA conditions) according 
to S(E)  [8]. A scaled quantity of DPK, called sDPK or F 
in literature, will be defined, with the purpose of 
studying it over a wide energy range, as follows 
F(r,E0 ) =
!E(r) / E0
!r / RCSDA
          (7) 
where r  is the distance to the source, !E(r)  is the 
energy fraction delivered to the body within r  and 
r + !r , E0  is the initial kinetic energy of the electron 
and RCSDA is the electron range in the CSDA for E0 . 
Besides, F  can be described as a function of S(E)  as 
follows [11] 
F (r,E0 ) =
RCSDA S(E(r, RCSDA ))
E0
= S(E (r, RCSDA ))S         (8) 
where the parameter S = E0RCSDA
 has been introduced. 
In this sense, F  can be interpreted as the ratio of S(E)  
in a particular point on the electron track and its value 
along the whole traveled path. 
2.1.3. Scaled DPK Approximation Modeling 
It can be directly performed a generalization of 
expression (8) for the emission due to an arbitrary 
spectrum P(E)  over an energy range Emin, Emax[ ] . Thus, 
this model can be applied for realistic radionuclides 
dosimetric calculations. 
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where ! j  and Ej  are the corresponding weight factor 
and discrete energy for the spectrum P(E) . 
Moreover, Bethe-Bloch S(E) expression for charged 
particles at relativistic energies can be written as [13] 
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where e and m0 represents electron charge and rest 
mass, respectively. zp  and vp  are the atomic number 
and velocity of the incident particle, NA  is the 
Avogadro’s number and Mµ  is the molar mass 
constant. Finally, ! , Z , I  and A represent mass 
density, effective atomic number, mean ionization 
energy and relative atomic mass of the absorber 
medium, respectively.  
It can be inferred from expression (10) that for non-
relativistic conditions the last two terms of the equation 
are closed to zero and might not be considered for a 
first approach. However, a rigorous analysis for TRT 
applications may take into account theses terms (e.g. 
for a 100keV kinetic energy on incident particle results 
in v2 / c2 ! 0.3 ). 
It is desirable to approximate an expression of an 
unknown F  by means of an already known scaled 
DPK considering only a few parameters of the material 
of interest. This possibility would avoid the need of 
calculating F  for every tissue and every radioisotope 
and, therefore, only a reduce quantity of F  estimations 
would be necessary for each radioisotope. Then, F  
could be assessed from the known data of the 
reference material. From equation (8) it follows that 
Fmed
Fref
= SmedSmed
Sref
Sref
        (11) 
where subscripts med and ref refer to absorber and 
reference medium, respectively. Then, equation (11) 
can be rewritten as 
      (12) 
where = Sref / Smed and  can be 
expressed, according to Beth-Bloch expression (10), in 
terms of E as [14] 
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where notation aij means 
aj
ai
 and 
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While energies involved in TRT procedures range 
from a few hundred eV to the order of MeV, the really 
important issue is that useful resolutions for dosimetric 
distribution estimations varies from 1 to 3 mm 
according to resolution achieved by commonly clinical 
machines, i.e. PET, CT. So, an analysis on E ∈ 
(100eV, 1MeV) is enough for these purposes, 
especially considering the low values of RCSDA  for 
electrons traveling in water with low energies (e.g. 
RCSDA = 0.00025cm  for 10 keV). 
When considering radiation transport in TRT 
procedures, materials correspond to human tissues 
that present mean ionization energy similar to water’s, 
Iwat . Then, water is established as the reference 
medium and it will be used for F calculations by means 
of the well-known and extensively published water 
F curve on different conditions. Considering electron 
initial energies between 100eV and 1MeV then !(E)  
ranges from 400eV to 7.91MeV. Besides, for studied 
tissues with ionization energies from 72.3 to 106.4 eV 
then !(E) / I  ranges from 109.46keV to 4eV and finally 
ln(!(E) / I )∈ (1.5,11.6). Moreover, the results of 
valuating !(E)  for that energy range are between 
0.00039 and 0.88563. Thus, the influence of !(E) is at 
most 8.45% and equation (13) can be approximated, in 
first approach, to 
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Lastly, from (12) and (15) it is found an expression 
to obtain scaled DPK for electron’s energies and 
materials of interest in nuclear medicine from a 
previously known curve for water as 
Fmed ! "watmedZwatmedAmedwat Rwatmed Imedwat Fwat  
Fmed ! " (#,Z,A,R, I )Fwat         (16) 
where R = RCSDA  and ! (",Z,A,R, I )  is a conversion 
factor associated with the proposed approach. In this 
last, second, approximation, the ratio of the ultimate 
term of expression (15) was taken as the ratio of its 
arguments. 
2.2. Scaled DPK Calculations 
Radial dose distributions were calculated around 
point monoenergetic electron sources within several 
infinite media by means of MC simulations. F  was 
calculated for each energy and material performing an 
extensive database of DPKs of interest. 
Each DPK calculation has been simulated within 
concentric spheres and the delivered energy was 
tallied in concentric shells of 0.025·RCSDA thicknesses 
up to 1.5·RCSDA. RCSDA values have been calculated 
following two methods: through PENELOPE MC 
general-purposes code libraries and and also by 
means of physical properties obtained from NIST 
(National Institute of Standards and Technology, USA) 
data tables through ESTAR online available software. 
In all cases the β− emission in biological tissues was 
studied and the corresponding F was calculated. 
A full stochastic calculation system was developed 
based on physics’ package of the PENELOPE v.2008 
[15] MC main code capable of voxel level radiation 
transport and dosimetry. Also, it can perform dosimetry 
over definite geometries and it is able to estimate 
delivered energy to user-defined bodies due to primary 
particles such as photons, electrons and positrons. 
Moreover, the developed system provides tools able to 
discriminate dose contributions due to primary and 
scattered particles. 
User interfaces, data analysis and visualization 
were developed both on a MATLAB platform and in 
scientific Python language, and simulations have been 
run in laboratory computers with i7 cores. 
2.3. Assessment of Uncertainties Involved in the 
Proposed Approach 
The approximations included in equations (13) and 
(15) may involve uncertainties because δ(E) was 
neglected. This approach implies differences (Dif) that 
can be evaluated by 
Dif =
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On the other hand, the second approximation 
consists on taking the ratio of the last term in equation 
(15) as the ratio of its arguments. Thus, this approach 
involves uncertainties that need to be accurately 
estimated too, following the same procedure that was 
shown in equation (17). 
2.4. Calculation of Kernels for Tissues 
According to the proposed method for the 
calculation of F it is necessary to introduce some 
specific physical parameters. At least !, Z , I  and A  
from both the medium from which F needs to be 
assessed and the chosen reference medium. As 
usually, liquid water was considered as reference 
material. Also, it is necessary to obtain the electron 
ranges for the corresponding media and energies and 
a well-known curve for Fwat . 
The considered biological tissues are defined in 
accordance to ICRP (brain, cortical bone, skeletal 
muscle, skin, lung, blood, adipose tissue and soft 
tissue) and ICRU (striated muscle and compact bone) 
formalisms and PENELOPE v.2008 MC code 
databases (liquid water). 
The effective atomic number has been calculated by 
the formula [16] 
Z 2.94 = ai Zi2.94
i=1
n
!          (18) 
where ai is the fraction of the total number of electrons 
associated with Zi  atomic number in the tissue 
molecule. While relative atomic mass A  has been 
calculated by [17] 
A = ai Ai
i=1
n
!          (19) 
where Ai  is de atomic mass of each element present in 
the tissue. 
Material mass density and corresponding mean 
ionization potential were obtained from PENELOPE 
database.  
2.5. Performance Evaluation and Applications 
Preliminary tests were carried out using a virtual 
phantom containing four spheres with different uniform 
activities emulating organs/tissues. Calculations 
considered emissions from homogeneous distribution 
of electron sources inside the spheres. 
A code written in Python computational language 
was developed to perform dosimetry through 
F convolution, and MC calculations for 3D dosimetry in 
the definite phantom have been run on the FLUKA MC 
code [18]. 
The calculations for F curves have been computed 
through MC simulation and the proposed model using 
water as reference medium. These methods were 
compared and analyzed along with their advantages 
and disadvantages. 
3. RESULTS 
3.1. Preliminary Analysis of the Implemented 
Approach 
Aiming at evaluating correctly the performance of 
equation (16) for the seven biological tissues of 
interest, it is necessary to quantify uncertainties 
involved in previous approaches, comprising this 
media. For all of this evaluations it is defined water as 
the reference material. Thus, first approximation is 
analyzed following equation (17) and it was found that 
the larger differences against the calculation of the full 
expression (10) in this approach are always less than 
2×10−4 whereas the lower differences, around 4×10−7 
correspond to soft tissue and blood. Figure 1 reports 
this calculated maximum and minimum differences. 
Then, it is necessary to evaluate the second 
approach where the ratio of the ultimate term of 
expression (15) was taken as the ratio of its arguments. 
An exhaustive analysis of these possible discrepancies 
was made. Then, results in the minimum and maximum 
differences are summarized in Figure 2. It is verified 
that differences due to the implementation of the 
method are always less than 0.0341 for soft tissue and 
the minimum value is found for blood (0.0018).  
Differences Brain Skin Blood Lung Soft Tissue Striat. Muscle Skel. Muscle 
Maximum (×10-6) 3.801 5.149 0.445 0.668 6.051 0.669 0.668 
Minimum (×10-4) 1.664 2.259 0.194 0.290 2.657 0.291 0.290 
 
Figure 1: Discrepancies for the first approximation in the proposed model. 
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3.2. Calculation of DPK  
The developed code was compared against results 
obtained by Botta et al. [19] with the purpose of 
establishing its accuracy and validation. This analysis 
shows a good agreement between results of both 
calculations, always within the statistic deviations. So, 
results obtained by Botta et al. are considered 
undistinguishable as regards the ones obtained using 
the developed system.  
A percentage variation parameter !F%  has been 
estimated according to the equation 
!F% = ( (FBotta " FCalculated ) / FCalculated )#100 . It shows 
higher differences at distances above r / RCSDA , just on 
the region where the delivered energy is closed to 0 
eV, so the main reason for the differences is due to 
statistical fluctuations that become relatively important 
when absolute magnitudes of calculated quantities 
goes to zero, like energy in this case. But, for example, 
1MeV electrons’ differences give !F%  lower than 0.7 
at distances within the RCSDA. 
Moreover, Figure 3 shows some results obtained for 
blood and soft tissues corresponding to monoenergetic 
electron point sources of 200 keV and 1 MeV initial 
kinetic energies, respectively. In these figures, F 
represents the MC calculated scaled DPK using the 
developed code, while Fprim  and Fscat  refer to primary 
and scattering contributions to the total F. 
Besides, considering only primary particles 
contributions, it results that there is no considerable 
variation on calculus uncertainties in energy variable. 
Figure 4 shows a case of in-brain simulations for 20 
keV and 2 MeV and variation within the RCSDA and in 
the peak zone never reaches 2%. 20 keV and 2 MeV 
correspond to the minimum and maximum studied 
initial electron kinetic energies, respectively. 
A detailed results analysis suggest a behavior that 
might be analyzed in three well-defined groups. The 
first one, where the model can be considered 
undistinguishable in comparison with MC calculations 
(differences < 5%): skin, blood and brain belong to this 
first group. The second one where the uncertainties 
have to be considered prior to evaluating the 
convenience of making dosimetry using the model 
(differences < 20%): skeletal muscle, soft tissue, 
striated muscle and adipose tissue are part of this 
Differences Brain Skin Blood Lung Soft Tissue Striat. Muscle Skel. Muscle 
Maximum  0.0156 0.0212 0.0018 0.0027 0.0251 0.0027 0.0027 
Minimum  0.0212 0.0289 0.0024 0.0036 0.0341 0.0037 0.0036 
 
Figure 2: Discrepancies for the second approximation in the proposed model. 
 
Figure 3: Results for F in blood (200 keV) and soft tissue (1 MeV) discriminating primary and scattering contributions to energy 
deposition. 
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group. And the third one, where the model, at least 
taking into account water as a reference medium, 
cannot be applied in the terms shown in this work 
(differences > 50%): compact and cortical bone, and 
lung tissue belong to this group. 
Finally, when the performance of the model is 
analyzed by using the total Fwat  MC assessed for 
calculations, the results are similar to the previous 
ones, but with increasing uncertainties. The first group 
has maximum uncertainties of 15% for initial source 
electron energies of 200keV but reaching 25% in some 
zones for 1MeV sources. The second group shows 
better results for the model than primary contribution 
calculations. In this case, the larger differences are 
found at 1MeV in adipose and soft tissues reaching 
20%, but in generally closed to 10%; while the third 
group is still not recommendable but in cases of 
compact and cortical bone the model presents 
differences lower than 50%.  
3.3. Applications of the Proposed Method 
Simulations were run on a virtual phantom 
considering four different spheres with different 
homogeneous activity in each one. A simplified version 
of typical applications was studied over this virtual 
phantom to evaluate the model performance against 
both standard DPK convolution and MC simulation 
methods. 
 
        (a) 
 
        (b) 
Figure 4: In-brain comparisons between MC and proposed model calculations from minimum (a) and maximum (b) initial 
electrons energies studied. 
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The model has been evaluated considering primary 
and total contributions to dose due to activity 
distribution in phantom. Primary contribution, as it was 
mentioned above, considers only the dose due to 
primary particles from the source; while total 
contribution considers all the different contributions to 
the dose, even secondary particles and scattering 
photons. 
Figure 5(a) reports results for brain tissue in 
phantom comparing standard DPK convolution against 
the proposed model taking into account only primary 
particles contributions to delivered dose. Figure 5(b) 
compares the same issue but considering differences 
between standard DPK convolutions against a MC 
simulation run on FLUKA MC code. Then, Figure 5(c) 
shows results of differences between the proposed 
model and MC simulation. 
  
(a) (b) 
 
        (c) 
Figure 5: Differences in dose distribution on brain comparing the proposed method considering only primary contribution with 
standard DPK convolution (a), DPK standard convolution versus MC (b) and proposed method versus MC (c). 
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Finally, Figure 6 shows results of differences 
between proposed model and the MC simulation run on 
FLUKA MC codeon striated muscle taking into account 
the whole dose (all of its contributions). 
 
Figure 6: Differences in dose distribution on striated muscle 
comparing the proposed method considering total 
contributions with MC simulation using FLUKA. 
4. DISCUSSION 
In view of the results reported for validation and the 
application of the model to dose distribution 
assessment by DPK calculations, it must be highlighted 
that it was found a promising overall performance. The 
approach is consistent with the formalism of the main 
Boltzmann radiation transport equation incorporating 
the CSDA. It was proposed an approach for the scaled 
DPK as a function of the Stopping Power. Then, from 
Bethe-Bloch formulation it was possible to obtain the 
scaled DPK, F, for electron sources in definite media 
by means of a previously well-known reference one. 
Looking for materials of interests in TRT proce- 
dures, there were performed F for β− monoenergetic 
sources at several energies through both MC method 
and the proposed model. Also, it was developed a 
specific code aimed at calculating deposited dose 
taking into account discriminated contributions both 
from primary and secondary/scattered particles. An 
exhaustive analysis on the developed code shows that 
the results are undistinguishable from those presented 
in bibliography. 
Besides, a study of the proposed approaches for 
F calculation in the framework called “first 
approximation”, without consideration of !(E)  of 
expression (13), shows excessively large uncertainties. 
But, the further analysis based on the “second 
approximation” shows analytical uncertainties always 
<3% for energies and materials of interest in nuclear 
medicine practices. 
Finally, it was possible to compute F for a wide 
variety of cases using the proposed method taking 
water as the reference pattern. Moreover, it was shown 
how to implement the model in terms of primary and 
total contributions to the dose deposition. This kind of 
discrimination allows to evaluate the performance in 
both cases. A rigorous analysis establishes that 
secondary particles might exhibit, in average, minor 
increment in Linear Energy Transfer (LET) with respect 
to primary particles of higher energies. Thereby, this 
capacity of the calculation model may constitute a 
valuable tool to perform LET-weighted dosimetry and a 
more realistic evaluation case-by-case in future tools 
developments. 
It was found that, when considering the second 
group of materials, the model attains the best 
performance calculating with total (primary and 
scattering) dose; whereas the deviations of results 
obtained for the third group may constitute significant 
limitations for the direct implementation in nuclear 
medicine dosimetry. Some approaches and further 
modifications of the model aimed to incorporate 
effective traveled path according to mass density, 
currently under investigation, may provide improved 
performance. For now, it is not suitable to implement 
the method when involved materials like cortical bone, 
compact bone or lung tissue. 
As final remarks, it must be emphasized that this 
work presents a novel method that appears as a 
promising tool for dosimetric assessment by means of 
DPK convolution for at least six different biological 
tissues commonly involved in nuclear medicine 
dosimetry: brain, blood, skin, skeletal muscle, soft 
tissue, striated muscle and adipose tissue. Tissues with 
mass density and ionization energy away from water 
values are still under investigation and the proposed 
method in the current version should not be 
recommended in these cases. 
CONCLUSIONS 
It was possible to achieve an expression to evaluate 
the absorbed dose in different materials by means of 
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the Stopping Power function through analytical 
calculations based on fundamentals of radiation 
transport physics. The two proposed approaches for 
the calculation of F in terms of a reference F provided 
consistent results. Also, results summarized in Figures 
1 and 2 support that the theoretical background of the 
developed system can achieve a good performance for 
dosimetric purposes. 
The proposed model was satisfactory validated with 
published data [19] and MC simulations. In addition, 
preliminary tests performed on simplified, but somehow 
realistic, phantoms demonstrated the reliability of the 
proposed method also pointing out specific 
characteristics of its performance in different situations 
when compared with standard DPK and MC 
calculations. Actually, results show that the model 
attains good performance even in cases presenting in 
homogeneities thus converting the model into a more 
powerful tool to improve dosimetry in TRT. 
Finally, it was found that the method is ready to be 
implemented in dosimetric calculations involving brain, 
blood and skin, otherwise the use of the method for 
skeletal muscle, soft tissue, striated muscle and 
adipose tissue must be taken carefully considering the 
important uncertainties involved, and by last it was 
established that the method is not suitable yet for 
applications were dosimetry needs to be performed on 
compact and cortical bone and lung tissue. 
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